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==========================

Airway mucus plays an important role in defense against invading airborne particles, foreign irritants, chemicals, and pathogenic microorganisms. Excessive mucus production is a major pathological event contributing to airway obstruction, atelectasis, impairment of gas exchange, and antibiotic permeability.\[[@ref1][@ref2]\] Mucins are a family of high-molecular-weight, heavily glycosylated proteins that are the most important constituent of mucus. At least 21 human mucin genes have been distinguished by cDNA cloning. Mucin 5AC (*MUC5AC*) is a gel-forming mucin predominantly expressed in airway epithelial cells; its expression is up-regulated in chronic inflammatory airway diseases such as chronic obstructive pulmonary disease, asthma, and cystic fibrosis.\[[@ref3][@ref4][@ref5]\] Several natural products are reported to affect airway mucin production.\[[@ref6][@ref7]\] We, therefore, sought to identify natural medicinal compounds to inhibit *MUC5AC* overexpression. Curcumin (CUR), a polyphenolic compound of turmeric (*Curcuma longa*) and a pharmacologically safe agent, has been shown to exert various biological effects through its antioxidant, anticancer, and anti-inflammatory properties.\[[@ref8][@ref9]\] CUR is also known to inhibit paraquat-induced lung inflammation and fibrosis in mice.\[[@ref10]\] A recent study demonstrated that CUR may inhibit *MUC5AC* production induced by epidermal growth factor (EGF) or interleukin (IL)-1beta in human airway epithelial cells.\[[@ref11][@ref12]\] However, whether CUR plays the same role in mucus overproduction *in vivo* and the underlying mechanism remain to be elucidated.

*Pseudomonas aeruginosa* is an important and opportunistic human respiratory pathogen associated with serious chronic inflammatory airway disease, especially hospital-acquired infections such as ventilator-associated pneumonia and sepsis. Lipopolysaccharide (LPS), a major component of *P. aeruginosa*, is one of the most potent inducers of mucus overproduction.\[[@ref13][@ref14]\] We sought to identify the role of CUR in LPS-induced *MUC5AC* mucin production, as well as the underlying mechanism.

Recent studies have shown that excessive oxidative stress plays an important role in *MUC5AC* mucin expression. Reactive oxygen species (ROS) are involved in the *MUC5AC* production induced by LPS, cigarette smoke, phorbol 12-myristate 13-acetate, and neutrophil elastase.\[[@ref14][@ref15][@ref16]\] Nuclear factor erythroid 2-related factor-2 (*Nrf2*), a member of the cap 'n' collar basic leucine zipper transcription factor family, is a critical regulator of defense against oxidative damage. *Nrf2* is thought to protect lung and other tissues against oxidative insults such as those caused by bacterial endotoxin, inflammatory factors, cigarette smoking, and hyperoxia.\[[@ref17][@ref18][@ref19]\]

Qi *et al*.\[[@ref16]\] reported that *Nrf2* is involved in neutrophil elastase-induced *MUC5AC* expression in human airway epithelial cells. Our laboratory has previously shown that *Nrf2* ameliorates cigarette smoking-induced mucus overproduction in airway epithelium and mouse lung.\[[@ref20]\] CUR is recognized to induce *Nrf2* activation and to protect cells and tissues against oxidative insult, airway inflammation, and lung carcinogenesis.\[[@ref21][@ref22][@ref23]\]

Despite extensive study of CUR\'s role in the treatment of lung disorders, little is known about the effect of CUR on LPS-induced *MUC5AC* mucin expression or about the role of *Nrf2* in this process. In the present study, we attempted to explore whether CUR regulates the production of *MUC5AC* induced by LPS in airway epithelial cells and mouse lung. To confirm the specific role of *Nrf2* in mucin regulation of CUR, we investigated whether knockdown of *Nrf2* with *Nrf2* small interfering RNA (siRNA) could influence *MUC5AC* expression in NCI-H292 cells. We demonstrated that CUR protected against LPS-induced *MUC5AC* mucin production and that the process was mediated, in part, by *Nrf2*. Based on its antioxidant effects, we identified CUR as a potential agent for prevention of mucus hypersecretion in chronic inflammatory airway disease.

M[ETHODS]{.smallcaps} {#sec1-2}
=====================

Materials and reagents {#sec2-1}
----------------------

RPMI-1640 and fetal bovine serum (FBS) were from Gibco (Grand Island, NY, USA). LPS, CUR (purity: 98%) and methylthiazolyltetrazolium (MTT) were purchased from SigmaAldrich (St. Louis, MO, USA). TRIzol reagent was Invitrogen (Carlsbad, CA, USA). Total RNA isolation and reverse transcription systems were obtained from Promega (Madison, WI, USA). Antibodies against human *MUC5AC* (45M1) was from Thermo Fisher Scientific (Rockford, IL, USA. Lot. PJ1926761). Antibodies against mouse *MUC5AC*, *Nrf2*, and β-actin were from Abcam (Cambridge, MA, USA. Lot. GR257950-1, GR37038-9, and GR212262-9). Antibodies against human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were from Abway (China. Lot. F011207).

Cell culture and measurement of cellular toxicity {#sec2-2}
-------------------------------------------------

A human pulmonary mucoepidermoid carcinoma cell line, NCI-H292, was purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA) and cultured in RPMI 1640 medium supplemented with 10% (vol/vol) FBS at 37°C in a humidified, 5% CO~2~/95% air, water-jacketed incubator. Before experimentation, confluent NCI-H292 cells were washed twice with phosphate-buffered saline (PBS) and recultured in serum-free RPMI 1640 overnight to maintain low basal levels of *MUC5AC* expression. After serum deprivation, the cells were pretreated with varying concentrations of CUR for 30 min and treated with LPS (10 μg/ml) for 24 h in serum-free RPMI 1640. The LPS and CUR were dissolved in RPMI 1640 and dimethylsulfoxide, respectively. The final concentrations of dimethylsulfoxide were 0.5%, which did not affect mucin gene expression and production. The cytotoxicity was determined by the conventional 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay, following exactly as the supplier\'s protocol.

Transfection {#sec2-3}
------------

The human *Nrf2* siRNA or the scrambled RNA as a negative control (Invitrogen, USA) were transfected into NCI-H292 cells using Lipofectamine 2000 (Invitrogen, USA), according to the manufacturer\'s protocol. Briefly, cells were seeded in 6-well tissue culture plates at a density of 5 × 10^5^ cells/ml, until they reached 50--70% confluency. Next, 100 nmol/L siRNA in 1 ml growth medium was incubated with NCI-H292 cells for 24 h. Then, infection medium was removed and replaced with fresh growth medium.

Measurement of intracellular reactive oxygen species {#sec2-4}
----------------------------------------------------

A ROS detection Kit (Enzo Life Sciences, Farmingdale, NY, USA) was used to measure the total ROS generated by LPS following the manufacturer\'s protocol. Briefly, 5 × 10^5^ cells were seeded in each well of 6-well plates and grown to 70--80% confluency. After overnight serum starvation, the cells were co-treated with CUR and LPS for 24 h. The medium was then replaced with a ROS wash buffer containing ROS detection solution. The fluorescence intensity was measured using a flow cytometry.

Animals {#sec2-5}
-------

The 8--10-week-old C57BL/6 mice were purchased from the Experimental Animal Center of Fujian Medical University (No. 2015000515917 and No. 2015000518707). All animal protocols and procedures were approved by the Animal Ethics Committee of the Second Affiliated Hospital of Fujian Medical University. Mice were pretreated with intraperitoneal injection of CUR (50 mg/kg) or vehicle. After 2 h of CUR administration, mice were treated with 100 μg LPS (in 50 μl saline) by intratracheal instillation and sacrificed after 6 days. Control mice received the same volume of saline.

Bronchoalveolar lavage fluid and airway inflammation analysis {#sec2-6}
-------------------------------------------------------------

Mouse tracheas were cannulated, and bronchoalveolar lavage fluid (BALF) was obtained by injecting 0.4 ml PBS into the right lungs (twice). After the total number of BALF cells was counted, remaining BALF was centrifuged at 400 *×g* for 10 min at 4°C. Cell pellets were spun onto glass microscope slides and stained with Wright-Giemsa (Baso). Total cells and neutrophils counts were assessed through light microscopy.

Lung histology {#sec2-7}
--------------

After BALF collection, the left lungs were fixed in 10% formalin for 24 h and then embedded in paraffin. The lung tissues were stained with hematoxylin and eosin (H&E) or periodic acid-Schiff\'s (PAS) following standard protocols. The extent of inflammation was assessed according to published guidelines. To measure airway mucus production, PAS-stained goblet cells in airway epithelium were scored, as described previously.\[[@ref22]\]

RNA isolation and quantitative real-time polymerase chain reaction {#sec2-8}
------------------------------------------------------------------

Total RNA from cells and lung homogenate was isolated with Trizol Reagent (Invitrogen) and reverse-transcribed with the Reverse Transcription Reagent Kit (TaKaRa Biotechnology, Japan), according to the manufacturer\'s instructions. The mRNA expression of *MUC5AC* and *Nrf2* was measured by quantitative real-time polymerase chain reaction (PCR), using SYBR Green Master Mix (TaKaRa Biotechnology, Japan) on a StepOne real-time PCR system (Applied Biosystems, Foster City). PCR primers used in the study are listed in [Table 1](#T1){ref-type="table"}.

###### 

Primers for quantitative real-time PCR analysis

  Species                           Genes          Primer sequence (5'- 3')
  --------------------------------- -------------- ----------------------------------
  Human                             *GAPDH*        Forward: TGCCACTCCTCCACCTTTG
  Reverse: CGAACCACCCTGTTGCTGT                     
  Human                             *MUC5AC*       Forward: CAGCACAACCCCTGTTTCAAA
  Reverse: GCGCACAGAGGATGACAGT                     
  Human                             *Nrf2*         Forward: AAACCAGTGGATCTGCCAAC
  Reverse: ACGTAGCCGAAGAAACCTCA                    
  Mouse                             *Beta-actin*   Forward: GGCTGTATTCCCCTCCATCG
  Reverse: CCAGTTGGTAACAATGCCATGT                  
  Mouse                             *MUC5AC*       Forward: CTGTGACATTATCCCATAAGCCC
  Reverse: AAGGGGTATAGCTGGCCTGA                    
  Mouse                             *Nrf2*         Forward: GGACATGGAGCAAGTTTGGC
  Reverse: GCTGGGAACAGCGGTAGTATC                   

PCR: Polymerase chain reaction; *GAPDH*: Glyceraldehyde-3-phosphate dehydrogenase; *MUC5AC*: Mucin 5AC; *Nrf2*: Nuclear factor erythroid 2-related factor 2.

Western blotting {#sec2-9}
----------------

After LPS stimulation for 24 h, H292 cells were lysed in lysis buffer (Beyotime) and protease inhibitor cocktail (Roche Diagnostics, IN, USA), then subjected to 8--10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride membranes (Millipore, USA). Membranes were blocked with 5% skim milk and incubated with various primary antibodies in antibody diluent overnight at 4°C. The membrane was washed with Tris-buffered saline (TBS) containing 0.1% Tween 20 (TBS-T) and then incubated with the corresponding secondary antibody for 1 h. Immunoreactive bands were visualized with enhanced chemiluminescence (ECL, Thermo Scientific, USA).

Statistical analysis {#sec2-10}
--------------------

Statistical analyses were performed using SPSS 19.0 software (SPSS Inc., Chicago, IL, USA). All calculations were performed using GraphPad Prism version 5.0 statistical software (GraphPad Software, San Diego, CA, USA). Data were analyzed by a one-way analysis of variance (ANOVA). Student\'s *t*-test was used when two groups were compared. Data are presented as mean ± standard deviation (SD). A value of *P* \< 0.05 was considered statistically significant.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

Effect of curcumin on lipopolysaccharide-induced mucin 5AC expression in NCI-H292 cells {#sec2-11}
---------------------------------------------------------------------------------------

To confirm whether LPS can induce *MUC5AC* production in NCI-H292 cells, we evaluated the *MUC5AC* mRNA expression after addition of LPS to the cells at various concentrations for different times. Consistent with previous reports, we found that stimulation with LPS led to a time-dependent and dose-independent increase in MUC5AC expression. This effect was most apparent after treatment with 10 μg/ml LPS for 24 h \[Figure [1a](#F1){ref-type="fig"} and [1b](#F1){ref-type="fig"}\]. Compared with the control group, the expression of MUC5AC mRNA and protein in LPS group is 7.169 ± 1.785 (*t* = −5.981, *P* \< 0.01) and 2.340 ± 0.209 (*t* = −11.101, *P* \< 0.01), respectively \[[Figure 1](#F1){ref-type="fig"}\].

![Effect of curcumin on *MUC5AC* expression induced by lipopolysaccharide in NCI-H292 cells. (a) *MUC5AC* mRNA expression induced by LPS at different concentrations. (b) *MUC5AC* mRNA expression induced by LPS in time-dependent manners. (c) Curcumin reduced *MUC5AC* mRNA expression in dose-dependent manners. (d) Curcumin inhibited LPS-induced MUC5AC protein expression. The values are expressed as mean ± standard error; \**P* \< 0.05, compared with control group; ^†^*P* \< 0.05, compared with LPS group. MUC5AC: Mucin 5AC; LPS: Lipopolysaccharide; CUR: Curcumin; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase.](CMJ-131-1686-g001){#F1}

In order to assess the effect of CUR on LPS-induced *MUC5AC* expression in human NCI-H292 cells, mRNA, and protein expression of MUC5AC was measured by real-time PCR and Western blotting. Cells were pretreated with CUR for 30 min before the addition of 10 μg/ml LPS. There was no significant damage to NCI-H292 cells when the concentration of CUR was \<40 μmol/L (data not shown). Compared with LPS group, the expression of MUC5AC mRNA (2.424 ± 0.318 vs. 7.169 ± 1.785, *t* = 4.534, *P* \< 0.05) and protein (1.060 ± 0.197 vs. 2.340 ± 0.209, *t* = 7.716, *P* \< 0.05) significantly decreased after treatment with CUR in a dose-dependent manner, respectively \[Figure [1c](#F1){ref-type="fig"} and [1d](#F1){ref-type="fig"}\].

Curcumin reduced levels of reactive oxygen species in NCI-H292 cells {#sec2-12}
--------------------------------------------------------------------

ROS levels, as determined by flow cytometry, were significantly higher in the LPS group than those in the control group. However, pretreatment with CUR resulted in significant decrease in ROS production after exposure to LPS \[[Figure 2](#F2){ref-type="fig"}\].

![Curcumin decreased LPS-induced ROS content in NCI-H292 cells. NCI-H292 cells were treated with curcumin and LPS, stained with Total ROS detection reagent and analyzed using flow cytometry. Untreated cells were used as a control. The fluorescence intensity was measured using a flow cytometry. ROS content in (a) group control, (b) group LPS, (c) group LPS + CUR. (d) Comprehensive comparison of three groups. LPS: Lipopolysaccharide; CUR: Curcumin; ROS: Reactive oxygen species.](CMJ-131-1686-g002){#F2}

Curcumin induced nuclear factor erythroid 2-related factor 2 activation in NCI-H292 cells {#sec2-13}
-----------------------------------------------------------------------------------------

In order to investigate the possible role of *Nrf2* in CUR-mediated inhibition of mucus production, we further analyzed mRNA and protein expression of *Nrf2* in NCI-H292 cells that had been preincubated with 40 μmol/L CUR for 30 min before exposure to 10 μg/ml LPS for 24 h. CUR significantly increased *Nrf2* mRNA and protein expression in NCI-H292 cells, compared with the LPS group (1.952 ± 0.340 vs. 1.142 ± 0.176, *t* = −3.661, and 2.010 ± 0.209 vs. 1.089 ± 0.132, *t* = −6.453, both *P* \< 0.05, respectively) \[Figure [3a](#F3){ref-type="fig"} and [3b](#F3){ref-type="fig"}\].

![Curcumin inhibited LPS-induced MUC5AC hypersecretion via nuclear factor erythroid 2-related factor 2 in NCI-H292 cells. (a) Curcumin induced *Nrf2* mRNA activation in NCI-H292 cells. (b) Curcumin activated *Nrf2* protein expression. *Nrf2* siRNA suppressed the inhibitory activity of curcumin against *MUC5AC* mRNA (c) and protein (d) production induced by LPS in NCI-H292 cells. The values are expressed as mean ± standard error; \**P* \< 0.05, compared with LPS group; ^†^*P* \< 0.05, compared with LPS + negative siRNA group; ^‡^*P* \< 0.05, compared with LPS + *Nrf2* siRNA group. MUC5AC: Mucin 5AC; Nrf2: Nuclear factor erythroid 2-related factor 2; LPS: Lipopolysaccharide; CUR: Curcumin; siRAN: small interfering RNA.](CMJ-131-1686-g003){#F3}

Nuclear factor erythroid 2-related factor 2 small interfering RNA suppressed the protective effect of curcumin on lipopolysaccharide-induced mucin 5AC expression in NCI-H292 cells

To confirm the involvement of *Nrf2* in CUR\'s inhibition of LPS-induced MUC5AC mucin production, we used *Nrf2* siRNA to knockdown *Nrf2*. MUC5AC expression in NCI-H292 cells were examined by real-time PCR and Western blotting. As shown in Figure [3c](#F3){ref-type="fig"} and [3d](#F3){ref-type="fig"}, *Nrf2* siRNA (100 nmol/L) significantly decreased expression of *Nrf2* mRNA and protein in NCI-H292 cells. Compared with the negative-siRNA + LPS group, knockdown of *Nrf2* with *Nrf2* siRNA increased MUC5AC mRNA expression by 47.7% (6.845 ± 1.478 vs. 3.391 ± 0.517, *t* = −3.821, *P* \< 0.05). Using mouse monoclonal antibody to MUC5AC (clone 45 M1, 1:100), we confirmed that *Nrf2* siRNA markedly increased MUC5AC protein expression in NCI-H292 cells. These results suggest that *Nrf2* is partly involved in the inhibitory activity of CUR against LPS-induced MUC5AC expression in airway epithelial cells.

Effect of curcumin on lipopolysaccharide-induced mucin 5AC and nuclear factor erythroid 2-related factor 2 production *in vivo* {#sec2-14}
-------------------------------------------------------------------------------------------------------------------------------

After establishing that CUR inhibits LPS-induced MUC5AC expression through *Nrf2* *in vitro*, we sought to evaluate the same phenomenon *in vivo*. We found that CUR (50 mg/kg) significantly decreased LPS-induced mRNA and protein expression of MUC5AC in mouse lung (1.672 ± 0.721 vs. 5.961 ± 2.452, *t* = 2.906, and 0.480 ± 0.191 vs. 2.290 ± 0.834, *t* = 3.665, respectively; both *P* \< 0.05) \[Figure [4a](#F4){ref-type="fig"} and [4c](#F4){ref-type="fig"}\], and also suppressed mucin production as demonstrated by Alcian blue/PAS stain \[[Figure 4d](#F4){ref-type="fig"}\]. As shown in Figure [4b](#F4){ref-type="fig"} and [4c](#F4){ref-type="fig"}, CUR significantly increased *Nrf2* mRNA and protein expression, compared with levels observed in the LPS group (2.076 ± 0.097 vs. 0.953 ± 0.263, *t* = −6.924, and 2.303 ± 0.295 vs. 1.089 ± 0.132, *t* = −6.499; both *P* \< 0.01, respectively).

![Effect of curcumin on LPS-induced *MUC5AC* and *Nrf2* production *in vivo*. Curcumin significantly decreased LPS-induced *MUC5AC* mRNA (a) and protein (c) expression in mouse lung tissue, with activation of *Nrf2* mRNA (b) and protein (c) expression. (d) AB/PAS staining shows that curcumin suppressed mucin production (arrows, ×200). Protein expression as normalized to GADPH. All values are expressed as mean ± standard error; *n* = 7 per group; \**P* \< 0.05, compared with LPS group. MUC5AC: Mucin 5AC; *Nrf2*: Nuclear factor erythroid 2-related factor 2; LPS: Lipopolysaccharide; CUR: Curcumin; AB/PAS: Alcian blue/periodic acid-Schiff.](CMJ-131-1686-g004){#F4}

Curcumin decreased lipopolysaccharide-induced inflammatory cells in bronchoalveolar lavage fluid and lung tissue of mice {#sec2-15}
------------------------------------------------------------------------------------------------------------------------

As a major component of gram-negative bacteria, LPS increases airway mucin secretion and induces airway inflammation. To evaluate the effects of CUR on LPS-induced inflammation in mouse lung, we counted the numbers of inflammatory cells and neutrophils in BALF and lung tissue of mice pretreated with CUR for 2 h before exposure to LPS for 7 days. Compared with LPS group, the numbers of total inflammatory cells (247 ± 30 vs. 334 ± 24, *t* = 3.901, *P* \< 0.05) and neutrophils (185 ± 22 vs. 246 ± 20, *t* = 3.566, *P* \< 0.05) in BALF decreased in the LPS + CUR group \[Figure [5a](#F5){ref-type="fig"} and [5b](#F5){ref-type="fig"}\]. Inflammatory cell infiltration in lung tissue was also reduced in CUR-treated mice, compared with LPS-challenged mice \[[Figure 5c](#F5){ref-type="fig"}\]. These data suggest that CUR might be involved in the regulation of LPS-induced airway inflammation *in vivo*.

![Curcumin decreased LPS-induced inflammatory cells in bronchoalveolar lavage fluid and lung tissue of mice. Curcumin decreased LPS-induced total inflammatory cells (a) and neutrophils (b) in BALF. (c) Curcumin reduced the infiltration of inflammatory cells in lung tissues (arrows, H and E, ×200). All values are expressed as mean ± standard error; *n* = 7 per group; \**P* \< 0.05, compared with LPS group. LPS: Lipopolysaccharide; CUR: Curcumin; BALF: Bronchoalveolar lavage fluid.](CMJ-131-1686-g005){#F5}

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

The study demonstrates that CUR inhibits LPS-induced MUC5AC mucin production and that this effect is mediated by Nrf2. The results presented above show that CUR suppressed LPS-induced *MUC5AC* mRNA and protein production, accompanied increased expression of *Nrf2* in alveolar epithelial NCI-H292 cells and mouse lung. *Nrf2* siRNA significantly blocked the protective activity of CUR against MUC5AC mucin expression induced by LPS in NCI-H292 cells.

Excessive mucus secretion is an important pathophysiological characteristic of chronic inflammatory airway diseases, and the regulation of mucus overproduction is a major therapeutic target. CUR has been reported to show anti-inflammatory, antioxidative stress and anticancer effects in respiratory epithelial cell. Heo *et al*. and Chang *et al*.\[[@ref11][@ref12]\] reported that CUR could inhibit the expression of MUC5AC induced by EGF or IL-1beta in NCI-H292 cells, respectively. LPS is a well-known pathogen for respiratory diseases, and also plays a significant role in the induction of MUC5AC expression. However, no previous study has reported that CUR regulates LPS-induced MUC5AC overproduction. We examined the effect of CUR on LPS-induced MUC5AC gene expression and mucin production in NCI-H292 cells and C57BL mice. The results presented above show that CUR suppressed the *MUC5AC* expression induced by LPS *in vitro* and *in vivo*; this effect was dose independent. CUR also inhibited the production of MUC5AC mucin protein induced by LPS. These results suggest that CUR regulates the mRNA and protein expression of mucin induced by LPS.

The mechanism by which CUR inhibits mucus production remains unclear. Numerous studies have reported the indispensable role of oxidative stress in LPS-induced mucin regulation. Our laboratory has reported that ROS and Duox1, one of the NADPH oxidases, are involved in LPS-induced MUC5AC expression in A549 cells and primary mouse tracheal epithelial cells.\[[@ref14]\] As an important transcription factor responsible for anti-oxidative stress and cytoprotection, the role of Nrf2 in mucins regulation has been investigated. Qi *et al*.,\[[@ref16]\] demonstrated that Nrf2 could regulate neutrophil elastase-induced MUC5AC expression in human airway epithelial cells. We found that Nrf2 ameliorated cigarette smoking-induced mucus overproduction in airway epithelium and mouse lungs.\[[@ref20]\] Soetikno *et al*.\[[@ref24]\] demonstrated that CUR alleviated oxidative stress, inflammation, and renal fibrosis in remnant kidney through the Nrf2-keap1 pathway. Kim *et al*.\[[@ref25]\] showed that CUR-mediated anti-inflammatory effects in LPS-stimulated macrophages through Nrf2 signaling. Liu *et al*.\[[@ref26]\] showed that CUR ameliorates asthmatic airway inflammation by activating Nrf2/HO-1 signaling pathway. However, there is none answer whether or not Nrf2 directly regulated the protective activity of CUR against MUC5AC mucin production induced by LPS. In the present study, we confirmed CUR attenuate LPS-induced ROS production and induce Nrf2 expression in NCI-H292 cells and mouse lungs. When Nrf2 expression was knockdowned by siRNA, the inhibitory effect of CUR against LPS-induced MUC5AC mucin expression was suppressed. These findings suggest that CUR might regulate LPS-induced mucus production through Nrf2 signaling.

The study had certain limitations. We should have included a rescue experiment by adding back Nrf2 after siRNA knockdown. Experiments on *Nrf2*^-/-^ mice would have been useful to confirm the role of *Nrf2* in mediating CUR\'s inhibition of LPS-induced mucin overproduction.

In conclusion, the results presented above demonstrate that CUR inhibits LPS-induced mucus production partly through activation of Nrf2. The findings presented in this study might provide novel insight into the development of new drugs against mucus hypersecretion. CUR represents a promising candidate for a therapeutic intervention in inhibit mucus hypersecretion in chronic inflammatory airway disease.
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